Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 11,509,300 | 11,168,900 | 9,460,622 | 11,644,290 | 11,509,360 |
| Cost of Goods | 4,164,210 | 3,726,843 | 3,038,964 | 4,097,919 | 4,196,332 |
| Gross Profit | 7,345,092 | 7,442,060 | 6,421,658 | 7,546,371 | 7,313,022 |
| Operating Expenses | 5,868,600 | 5,042,738 | 2,886,057 | 4,967,355 | 4,840,268 |
| Operating Income | 1,476,709 | 2,400,164 | 3,536,565 | 2,579,934 | 2,473,087 |
| Interest Expense | 315,912 | 251,901 | 284,166 | 293,349 | 265,952 |
| Other Income | -334 | 10,335 | 24,818 | 64,050 | 18,819 |
| Pre-tax Income | 1,160,463 | 2,158,598 | 3,277,217 | 2,350,635 | 2,225,954 |
| Income Tax | -15,861 | 311,324 | 249,421 | 199,836 | 248,192 |
| Net Income Continuous | 1,176,323 | 1,847,274 | 3,027,796 | 2,150,799 | 1,977,762 |
| Minority Interests | 214,528 | 240,275 | 219,639 | 146,034 | 280,823 |
| Net Income | $961,795 | $1,606,999 | $2,808,156 | $2,004,765 | $1,696,939 |
| EPS Basic Total Ops | 0.48 | 0.81 | 1.41 | 1.01 | 0.86 |
| EPS Basic Continuous Ops | 0.59 | 0.93 | 1.52 | 1.08 | 1.00 |
| EPS Diluted Total Ops | 0.47 | 0.80 | 1.40 | 1.00 | 0.84 |
| EPS Diluted Continuous Ops | 0.58 | 0.92 | 1.51 | 1.07 | 0.98 |
| EBITDA(a) | $4,921,686 | $3,178,784 | $2,083,137 | $2,828,448 | $2,405,150 |